UNSPSC 41131721: Whole blood hemoglobin assays

In this classification a whole blood hemoglobin assay is a device consisting or reagents, calibrators, controls, or photometric or spectrophotometric instrumentation used to measure the hemoglobin content of whole blood for the detection of anemia. This generic device category does not include automated hemoglobin systems US FDA regulates Whole blood hemoglobin assays under 21 CFR 864.7500 and under FDA product code KHG.

UNSPSC 41131721 Whole blood hemoglobin assays is a Commodity code that in recent state and local procurement activity spans drug and alcohol screening, forensic laboratory testing, and clinical laboratory diagnostics—not isolated hemoglobin measurement but rather comprehensive specimen analysis tied to law enforcement, occupational health, and municipal public health operations. State and local buyers soliciting under this code include county criminal justice and community supervision departments, city public safety and health functions, county health care services, county forensic laboratories, and county public health programs. The work ranges from offender specimen collection and multi-panel drug screening (immunoassay with LC/MS/MS or GC/MS confirmation) to urinalysis testing for treatment court programs, forensic drug analysis supporting seized-evidence work, and occupational medical screening tied to pre-employment and fitness-for-duty evaluations. Vendors must typically hold SAMHSA, state DPS, or CAP lab certification; comply with CLIA and HIPAA; and deliver electronic result reporting through secure web-based portals or EHR integration.

Recent activity clusters in Texas, Georgia, Florida, and Oregon, with additional solicitation from North Carolina and New Mexico. Collin County, Texas (Community Supervision and Corrections Department) posted RFP 2026-327 for offender specimen collection and drug testing services with approximately 25,031 tests annually ($600,000 estimated value, responses due July 23, 2026), and Collin County Health Care Services separately solicited laboratory services including drug panel testing through IFB 2025-166 (responses due October 2, 2025, $70,000 estimated annual value). Benton County, Oregon requested urinalysis testing proposals for its Family Treatment Court Program (responses due July 6, 2026) with twice-weekly testing and secure web-based result reporting. Gwinnett County, Georgia is procuring drug testing supplies for an existing drugs-of-abuse analyzer (RFQ responses due October 14, 2026). The Texas Comptroller Statewide Procurement Division issued IFB 304T-27-175A1.1 for proprietary laboratory consumables and reagents including drug screening kits and ELISA materials for cannabinoids, opiates, amphetamines, and controlled substances, serving the Texas Department of Public Safety statewide (responses due October 20, 2026). Pinellas County, Florida procured certified drug reference standards for forensic laboratory toxicology and seized-drug analysis (ITQ 26-0305-ITQ, responses due April 23, 2026, $72,126.85 federally funded through the Paul Coverdell Forensic Sciences Improvement Act).